FIA
BPMC

FNY Investment Advisers’s Blueprint Medicines BPMC Stock Holding History

FNY Investment Advisers’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8
Closed -$1K – 1254
2025
Q2 		$1K Buy
+8
New +$831 ﹤0.01% 882

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

FNY Investment Advisers's BPMC Position: Q3 2025 in Review

FNY Investment Advisers sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 41,060 shares — an estimated $5.26M sold.

FNY Investment Advisers first reported a position in BPMC in Q2 2018 and held it in 3 quarters. The position peaked at $5.26M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • FNY Investment Advisers reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 41,060 Blueprint Medicines shares in Q3 2025, an estimated $5.26M.
  • FNY Investment Advisers first reported a position in Blueprint Medicines in Q2 2018 and held it in 3 quarters.
  • FNY Investment Advisers's Blueprint Medicines position peaked at $5.26M in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.